Ilse Molendijk

1.4k total citations
17 papers, 1.0k citations indexed

About

Ilse Molendijk is a scholar working on Surgery, Genetics and Genetics. According to data from OpenAlex, Ilse Molendijk has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 6 papers in Genetics and 5 papers in Genetics. Recurrent topics in Ilse Molendijk's work include Inflammatory Bowel Disease (6 papers), Mesenchymal stem cell research (5 papers) and Anorectal Disease Treatments and Outcomes (5 papers). Ilse Molendijk is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Mesenchymal stem cell research (5 papers) and Anorectal Disease Treatments and Outcomes (5 papers). Ilse Molendijk collaborates with scholars based in Netherlands and United States. Ilse Molendijk's co-authors include Andrea E. van der Meulen‐de Jong, Hein W. Verspaget, C. Janneke van der Woude, Daniël W. Hommes, Helene Roelofs, Willem E. Fibbe, Marjolijn Duijvestein, Veerle J. Nuij, Koen Peeters and Bert A. Bonsing and has published in prestigious journals such as Immunity, Gastroenterology and Stem Cells.

In The Last Decade

Ilse Molendijk

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilse Molendijk Netherlands 13 518 440 318 215 197 17 1.0k
Brigitta Omazic Sweden 13 357 0.7× 773 1.8× 89 0.3× 338 1.6× 258 1.3× 19 1.5k
Shirine Dada United States 8 327 0.6× 250 0.6× 262 0.8× 141 0.7× 190 1.0× 10 861
Volker Benseler Germany 14 509 1.0× 489 1.1× 67 0.2× 161 0.7× 278 1.4× 22 1.3k
Óscar Quintana-Bustamante Spain 15 226 0.4× 206 0.5× 141 0.4× 116 0.5× 472 2.4× 32 999
Raghavan Chinnadurai United States 11 227 0.4× 482 1.1× 49 0.2× 153 0.7× 172 0.9× 18 758
Regiane Aparecida Cavinato Italy 16 564 1.1× 726 1.6× 66 0.2× 102 0.5× 318 1.6× 18 1.3k
Joan García‐López Spain 14 167 0.3× 337 0.8× 99 0.3× 210 1.0× 259 1.3× 20 1.1k
Chih‐Pin Liu United States 18 166 0.3× 247 0.6× 218 0.7× 121 0.6× 229 1.2× 29 1.1k
Hélder Trindade Portugal 17 185 0.4× 227 0.5× 57 0.2× 161 0.7× 353 1.8× 42 985
Erick P. Chan United States 6 230 0.4× 113 0.3× 83 0.3× 253 1.2× 362 1.8× 9 1.3k

Countries citing papers authored by Ilse Molendijk

Since Specialization
Citations

This map shows the geographic impact of Ilse Molendijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse Molendijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse Molendijk more than expected).

Fields of papers citing papers by Ilse Molendijk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilse Molendijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse Molendijk. The network helps show where Ilse Molendijk may publish in the future.

Co-authorship network of co-authors of Ilse Molendijk

This figure shows the co-authorship network connecting the top 25 collaborators of Ilse Molendijk. A scholar is included among the top collaborators of Ilse Molendijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse Molendijk. Ilse Molendijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Veenendaal, Roeland A., et al.. (2022). [Important rise in antibiotic resistance rates inHelicobacter pyloriin the Netherlands].. PubMed. 166. 1 indexed citations
2.
Steenhuis, Maurice, et al.. (2021). Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up. International Journal of Colorectal Disease. 37(2). 349–356. 9 indexed citations
3.
Molendijk, Ilse, Sander van der Marel, & Jeroen Maljaars. (2019). Towards a Food Pharmacy: Immunologic Modulation through Diet. Nutrients. 11(6). 1239–1239. 27 indexed citations
4.
Barnhoorn, Marieke C., Martin N.J.M. Wasser, Helene Roelofs, et al.. (2019). Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas. Journal of Crohn s and Colitis. 14(1). 64–70. 99 indexed citations
5.
Molendijk, Ilse, et al.. (2019). P592 Towards a Food Pharmacy: increased dietary quality reduces CRP and improves quality of life in IBD patients in remission. Journal of Crohn s and Colitis. 13(Supplement_1). S411–S411. 4 indexed citations
6.
Helm, Danny van der, Marieke C. Barnhoorn, Eveline S. M. de Jonge‐Muller, et al.. (2019). Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers. Journal of Cellular and Molecular Medicine. 23(9). 6238–6250. 19 indexed citations
7.
Barnhoorn, Marieke C., Ilse Molendijk, Mandy van Gulijk, et al.. (2018). Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis. Inflammatory Bowel Diseases. 24(8). 1755–1767. 18 indexed citations
8.
Molendijk, Ilse, Andrea E. van der Meulen‐de Jong, Hein W. Verspaget, et al.. (2018). Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn’s disease. European Journal of Gastroenterology & Hepatology. 30(10). 1148–1154. 12 indexed citations
9.
Barnhoorn, Marieke C., Astrid G. S. van Halteren, Melissa van Pel, et al.. (2018). Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn’s Fistulas: A Case Report. Journal of Crohn s and Colitis. 13(6). 807–811. 12 indexed citations
10.
Unen, Vincent van, Na Li, Ilse Molendijk, et al.. (2016). Mass Cytometry of the Human Mucosal Immune System Identifies Tissue- and Disease-Associated Immune Subsets. Immunity. 44(5). 1227–1239. 100 indexed citations
11.
Molendijk, Ilse, Marieke C. Barnhoorn, Eveline S. M. de Jonge‐Muller, et al.. (2016). Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis. Journal of Crohn s and Colitis. 10(8). 953–964. 22 indexed citations
12.
Molendijk, Ilse, Bert A. Bonsing, Helene Roelofs, et al.. (2015). Allogeneic Bone Marrow–Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease. Gastroenterology. 149(4). 918–927.e6. 252 indexed citations
13.
Molendijk, Ilse, Koen Peeters, Coen I.M. Baeten, Roeland A. Veenendaal, & Andrea E. van der Meulen‐de Jong. (2014). Improving the outcome of fistulising Crohn's disease. Best Practice & Research Clinical Gastroenterology. 28(3). 505–518. 8 indexed citations
14.
Molendijk, Ilse, Veerle J. Nuij, Andrea E. van der Meulen‐de Jong, & C. Janneke van der Woude. (2014). Disappointing Durable Remission Rates in Complex Crohnʼs Disease Fistula. Inflammatory Bowel Diseases. 20(11). 2022–2028. 118 indexed citations
15.
Molendijk, Ilse, Marjolijn Duijvestein, Andrea E. van der Meulen‐de Jong, et al.. (2012). Immunomodulatory Effects of Mesenchymal Stromal Cells in Crohn’s Disease. PubMed. 2012. 1–8. 14 indexed citations
16.
Duijvestein, Marjolijn, Ilse Molendijk, Helene Roelofs, et al.. (2011). Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy. 13(9). 1066–1073. 40 indexed citations
17.
Duijvestein, Marjolijn, Manon E. Wildenberg, Mick M. Welling, et al.. (2011). Pretreatment with Interferon-γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis. Stem Cells. 29(10). 1549–1558. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brigitta Omazic Breakdown of academic impact, for papers by Shirine Dada Breakdown of academic impact, for papers by Volker Benseler Breakdown of academic impact, for papers by Óscar Quintana-Bustamante Breakdown of academic impact, for papers by Raghavan Chinnadurai Breakdown of academic impact, for papers by Regiane Aparecida Cavinato Breakdown of academic impact, for papers by Joan García‐López Breakdown of academic impact, for papers by Chih‐Pin Liu Breakdown of academic impact, for papers by Hélder Trindade Breakdown of academic impact, for papers by Erick P. Chan
Rankless by CCL
2026